Gerd Sutter

13.3k total citations · 2 hit papers
211 papers, 10.0k citations indexed

About

Gerd Sutter is a scholar working on Epidemiology, Virology and Immunology. According to data from OpenAlex, Gerd Sutter has authored 211 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Epidemiology, 95 papers in Virology and 74 papers in Immunology. Recurrent topics in Gerd Sutter's work include Poxvirus research and outbreaks (71 papers), Virus-based gene therapy research (64 papers) and Herpesvirus Infections and Treatments (53 papers). Gerd Sutter is often cited by papers focused on Poxvirus research and outbreaks (71 papers), Virus-based gene therapy research (64 papers) and Herpesvirus Infections and Treatments (53 papers). Gerd Sutter collaborates with scholars based in Germany, United States and Netherlands. Gerd Sutter's co-authors include Bernard Moss, Caroline Staib, Volker Erfle, Ingo Drexler, Asisa Volz, H. Meyer, A. Mayr, Holger Ludwig, Robert Fux and Yasemin Suezer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Gerd Sutter

205 papers receiving 9.7k citations

Hit Papers

A Toll-like receptor–independent antiviral response i... 1992 2026 2003 2014 2005 1992 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA
    2005 642 citations Ken J. Ishii, Cevayir Coban et al. Nature Immunology profile →
  2. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
    1992 508 citations Gerd Sutter, Bernard Moss Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerd Sutter Germany 54 4.4k 3.9k 3.7k 2.4k 2.4k 211 10.0k
John W. Shiver United States 48 4.8k 1.1× 3.4k 0.9× 2.8k 0.8× 2.3k 0.9× 3.3k 1.4× 109 9.5k
Benhur Lee United States 63 5.3k 1.2× 4.4k 1.1× 4.3k 1.1× 4.1k 1.7× 3.3k 1.4× 202 13.1k
Christopher C. Broder United States 61 4.1k 0.9× 6.2k 1.6× 5.7k 1.5× 5.7k 2.3× 2.6k 1.1× 198 13.0k
Jeffrey B. Ulmer United States 55 7.0k 1.6× 3.7k 0.9× 1.6k 0.4× 4.1k 1.7× 5.7k 2.4× 143 13.2k
Persephone Borrow United Kingdom 58 9.7k 2.2× 3.6k 0.9× 5.8k 1.6× 4.0k 1.6× 2.4k 1.0× 159 15.3k
Paul A. Luciw United States 63 4.0k 0.9× 4.4k 1.1× 8.1k 2.2× 4.2k 1.8× 4.5k 1.9× 200 14.3k
Zhi-Yong Yang United States 39 2.4k 0.5× 2.1k 0.5× 2.2k 0.6× 3.1k 1.3× 2.1k 0.9× 54 7.0k
Thomas R. Fuerst United States 33 1.5k 0.3× 2.9k 0.7× 1.8k 0.5× 2.5k 1.0× 2.5k 1.1× 74 8.0k
Eric Hunter United States 65 4.1k 0.9× 4.0k 1.0× 10.1k 2.7× 5.7k 2.3× 4.2k 1.7× 297 14.9k
Greg J. Towers United Kingdom 54 3.5k 0.8× 2.5k 0.6× 4.9k 1.3× 2.9k 1.2× 3.3k 1.3× 118 8.9k

Countries citing papers authored by Gerd Sutter

Since Specialization
Citations

This map shows the geographic impact of Gerd Sutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Sutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Sutter more than expected).

Fields of papers citing papers by Gerd Sutter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Sutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Sutter. The network helps show where Gerd Sutter may publish in the future.

Co-authorship network of co-authors of Gerd Sutter

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Sutter. A scholar is included among the top collaborators of Gerd Sutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Sutter. Gerd Sutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rojas, Juan J., Lien Van Hoecke, Miquel À. Conesa, et al.. (2024). A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses. Molecular Therapy. 32(7). 2406–2422. 8 indexed citations
2.
Raadsen, Matthijs P., Mariana Garcı́a, Till Koch, et al.. (2024). Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach. iScience. 27(8). 110470–110470. 1 indexed citations
3.
Beythien, Georg, et al.. (2024). Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection. Viruses. 16(3). 417–417. 4 indexed citations
4.
Mayer, Leonie, Anahita Fathi, Maya Kono, et al.. (2024). MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans. npj Vaccines. 9(1). 20–20. 3 indexed citations
5.
Jany, Sylvia, Cornelius Rohde, Alexandra Kupke, et al.. (2023). Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice. Viruses. 15(5). 1180–1180. 6 indexed citations
6.
Raadsen, Matthijs P., Christine Dahlke, Anahita Fathi, et al.. (2023). Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome–Coronavirus Spike Protein. The Journal of Infectious Diseases. 228(5). 586–590. 8 indexed citations
7.
8.
Fux, Robert, et al.. (2021). Circular Rep-Encoding Single-Stranded DNA Sequences in Milk from Water Buffaloes (Bubalus arnee f. bubalis). Viruses. 13(6). 1088–1088. 9 indexed citations
9.
Gerlach, Thomas, et al.. (2020). Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise. Vaccines. 8(3). 451–451. 58 indexed citations
10.
11.
Brandmüller, Christine, et al.. (2013). Modified Vaccinia virus Ankara: Innate immune activation and induction of cellular signalling. Vaccine. 31(39). 4231–4234. 47 indexed citations
12.
Kreijtz, Joost H. C. M., Yasemin Suezer, Gerrie de Mutsert, et al.. (2009). Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses. Vaccine. 27(45). 6296–6299. 36 indexed citations
13.
Kreijtz, Joost H. C. M., Yasemin Suezer, Gerrie de Mutsert, et al.. (2008). Recombinant Modified Vaccinia Virus Ankara Expressing the Hemagglutinin Gene Confers Protection against Homologous and Heterologous H5N1 Influenza Virus Infections in Macaques. The Journal of Infectious Diseases. 199(3). 405–413. 64 indexed citations
14.
Cosma, Antonio, Caroline Staib, Franziska Wopfner, et al.. (2007). Evaluation of Modified Vaccinia Virus Ankara as an Alternative Vaccine against Smallpox in Chronically HIV Type 1-Infected Individuals Undergoing HAART. AIDS Research and Human Retroviruses. 23(6). 782–793. 25 indexed citations
15.
Ishii, Ken J., Cevayir Coban, Hiroki Kato, et al.. (2005). A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA. Nature Immunology. 7(1). 40–48. 642 indexed citations breakdown →
16.
Herrmann, F, Hans‐Anton Lehr, Ingo Drexler, et al.. (2004). HER-2/neu-Mediated Regulation of Components of the MHC Class I Antigen-Processing Pathway. Cancer Research. 64(1). 215–220. 107 indexed citations
17.
Lotz, Carina, Edite Antunes Ferreira, Ingo Drexler, et al.. (2003). Partial tyrosinase‐specific self tolerance by HLA‐A*0201‐restricted cytotoxic T lymphocytes in mice and man. International Journal of Cancer. 108(4). 571–579. 14 indexed citations
18.
Drexler, Ingo, Caroline Staib, Wolfgang Kastenmüller, et al.. (2002). Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proceedings of the National Academy of Sciences. 100(1). 217–222. 128 indexed citations
19.
Verrier, Bernard, Roger Le Grand, Yasemin Ataman‐Önal, et al.. (2002). Evaluation in Rhesus Macaques of Tat and Rev-Targeted Immunization as a Preventive Vaccine against Mucosal Challenge with SHIV-BX08. DNA and Cell Biology. 21(9). 653–658. 37 indexed citations
20.
Sutter, Gerd & Bernard Moss. (1992). Nonreplicating vaccinia vector efficiently expresses recombinant genes.. Proceedings of the National Academy of Sciences. 89(22). 10847–10851. 508 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John W. Shiver Breakdown of academic impact, for papers by Benhur Lee Breakdown of academic impact, for papers by Christopher C. Broder Breakdown of academic impact, for papers by Jeffrey B. Ulmer Breakdown of academic impact, for papers by Persephone Borrow Breakdown of academic impact, for papers by Paul A. Luciw Breakdown of academic impact, for papers by Zhi-Yong Yang Breakdown of academic impact, for papers by Thomas R. Fuerst Breakdown of academic impact, for papers by Eric Hunter Breakdown of academic impact, for papers by Greg J. Towers
Rankless by CCL
2026